fluconazole has been researched along with Intestinal Perforation in 7 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Intestinal Perforation: Opening or penetration through the wall of the INTESTINES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rats in Fp groups were given fluconazole in doses of 0 mg/kg, 3 mg/kg, 10 mg/kg, and 30 mg/kg by gavage 30 min before induction of peritonitis." | 7.72 | Fluconazole attenuates lung injury and mortality in a rat peritonitis model. ( Arshaduddin, M; Evans, DP; Jacobs, S; Khan, HA; Moutaery, AA; Tariq, M, 2003) |
| "Fluconazole, 400 mg/day, was given as EPT." | 5.33 | Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery. ( Lee, JC; Lin, PW; Shan, YS; Sy, ED; Wang, ST, 2006) |
| "Rats in Fp groups were given fluconazole in doses of 0 mg/kg, 3 mg/kg, 10 mg/kg, and 30 mg/kg by gavage 30 min before induction of peritonitis." | 3.72 | Fluconazole attenuates lung injury and mortality in a rat peritonitis model. ( Arshaduddin, M; Evans, DP; Jacobs, S; Khan, HA; Moutaery, AA; Tariq, M, 2003) |
| "Fluconazole, 400 mg/day, was given as EPT." | 1.33 | Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery. ( Lee, JC; Lin, PW; Shan, YS; Sy, ED; Wang, ST, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, X | 1 |
| Qiu, H | 1 |
| Li, R | 1 |
| Guo, F | 1 |
| Liu, W | 1 |
| Kang, M | 1 |
| Kang, Y | 1 |
| Khoury, W | 1 |
| Szold, O | 1 |
| Soffer, D | 1 |
| Kariv, Y | 1 |
| Wasserlauf, R | 1 |
| Klausner, JM | 1 |
| Ogorek, D | 1 |
| Weinbroum, AA | 1 |
| Holzknecht, BJ | 1 |
| Thorup, J | 1 |
| Arendrup, MC | 1 |
| Andersen, SE | 1 |
| Steensen, M | 1 |
| Hesselfeldt, P | 1 |
| Nielsen, JM | 1 |
| Knudsen, JD | 1 |
| Alvarez-Lerma, F | 1 |
| Nolla, J | 1 |
| Palomar, M | 1 |
| León, MA | 1 |
| Tariq, M | 1 |
| Moutaery, AA | 1 |
| Arshaduddin, M | 1 |
| Khan, HA | 1 |
| Evans, DP | 1 |
| Jacobs, S | 1 |
| Shan, YS | 1 |
| Sy, ED | 1 |
| Wang, ST | 1 |
| Lee, JC | 1 |
| Lin, PW | 1 |
| Sandven, P | 1 |
| Qvist, H | 1 |
| Skovlund, E | 1 |
| Giercksky, KE | 1 |
1 trial available for fluconazole and Intestinal Perforation
| Article | Year |
|---|---|
Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Double-Blind Method; Fem | 2002 |
6 other studies available for fluconazole and Intestinal Perforation
| Article | Year |
|---|---|
Risk factors for fluconazole-resistant invasive candidiasis in intensive care unit patients: An analysis from the China Survey of Candidiasis study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis, Invasive; Carrier State; Ch | 2015 |
Prophylactic fluconazole does not improve outcome in patients with purulent and fecal peritonitis due to lower gastrointestinal perforation.
Topics: Aged; Antifungal Agents; Dose-Response Relationship, Drug; Feces; Female; Fluconazole; Follow-Up Stu | 2010 |
Decreasing candidaemia rate in abdominal surgery patients after introduction of fluconazole prophylaxis*.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Ba | 2011 |
[Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Case Management; Consensus Development Conferences a | 2003 |
Fluconazole attenuates lung injury and mortality in a rat peritonitis model.
Topics: Adjuvants, Immunologic; Animals; Ascitic Fluid; Disease Models, Animal; Dose-Response Relationship, | 2003 |
Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Female; Fluconazole; Gastrointestina | 2006 |